Financial Conflicts of Interest in PHS-funded Research
In accordance with PHS regulations, this web page provides public access to information pertaining to Financial Conflicts of Interest (FCOI) of PHS-funded research. The information on this web page will remain available for three (3) years after its most recent update. Information required by PHS regulation:
- the covered individual’s name;
- the covered individual’s title and role with respect to the research;
- the name of the entity in which the financial interest is held;
- the nature of the financial interest that constitutes a financial conflict of interest; and
- the approximate value of the financial interest by range or, if the dollar value cannot be determined by reference to public prices or other reasonable measures of fair market value, a statement to that effect.
A management plan is established in cooperation with the Covered Individual to address the FCOI per University policy. The information posted on this website is derived from the management plan.
The FCOI posted on this website is current as of June 20, 2013 and is subject to updates, on at least an annual basis and within 60 days of the University’s identification of the FCOI.
Everett Stone, Ph.D.
Posted: January 23, 2013
Title and Role with Respect to the Research
Research Scientist and Principal Investigator
Name of Entity in which the Financial Interest is Held
GMA, LLC
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual holds equity interest in GMA, LLC and conducts research in areas of interest to GMA, LLC.
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
10% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Konstantin Sokolov, Ph.D.
Posted: March 22, 2013
Title and Role with Respect to the Research
Adjunct Associate Professor and Principal Investigator
Name of Entity in which the Financial Interest is Held
NanoHybrids, LLC.
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual is a founding member and on the board of directors of NanoHybrids, LLC. The Covered Individual holds equity interest in NanoHybrids, LLC and conducts research in areas of interest to NanoHybrids, LLC.
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
11-20% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Stanislav Emelianov, Ph.D.
Posted: March 29, 2013
Title and Role with Respect to the Research
Professor and Principal Investigator
Name of Entity in which the Financial Interest is Held
NanoHybrids, LLC.
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual and Covered Family Member are founding members and on the board of directors of NanoHybrids, LLC. The Covered Individual and Covered Family Member hold equity interest in NanoHybrids, LLC and the Covered Individual conducts research in areas of interest to NanoHybrids, LLC.
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
12-24% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Kenneth Diller, Ph.D.
Posted: May 8, 2013
Title and Role with Respect to the Research
Professor and Principal Investigator
Name of Entity in which the Financial Interest is Held
Bioheat Transfer, LLC and Cool Core Biomedical Technologies, LLC
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual is the President of Bioheat Transfer, LLC and the Chief Scientific Officer of Cool Core Biomedical Technologies, LLC. The Covered Individual holds equity interest in Bioheat Transfer, LLC and Cool Core Biomedical Technologies, LLC. The Covered Individual conducts research in areas of interest to Bioheat Transfer, LLC and Cool Core Biomedical Technologies, LLC
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
75% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value. (Bioheat Transfer, LLC)
45% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.(Cool Core Biomedical Technologies, LLC)
Sepideh Khoshnevis, MD
Posted: May 13, 2013
Title and Role with Respect to the Research
Graduate Research Assistant
Name of Entity in which the Financial Interest is Held
Bioheat Transfer, LLC
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual holds equity interest in Bioheat Transfer, LLC. The business interests of Bioheat Transfer, LLC overlap with the Covered Individual’s research.
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
22% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Robert Matthew Brothers, Ph.D.
Posted: May 13, 2013
Title and Role with Respect to the Research
Assistant Professor and Principal Investigator
Name of Entity in which the Financial Interest is Held
Bioheat Transfer, LLC
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual holds equity interest in Bioheat Transfer, LLC. The business interests of Bioheat Transfer, LLC overlap with the Covered Individual’s research.
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
3% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
George Georgiou, Ph.D.
Posted: May 13, 2013
Title and Role with Respect to the Research
Professor and Principal Investigator
Name of Entity in which the Financial Interest is Held
GMA, LLC
Nature of the Financial Interest that Constitutes a Financial Conflict of Interest:
The Covered Individual holds equity interest in GMA, LLC. The Covered Individual conducts sponsored research on intellectual property that has been assigned to GMA, LLC.
Approximate Value of the Financial Interest by Range, or If the Dollar Value Cannot Be Determined by Reference to Public Prices or Other Reasonable Measures of Fair market Value, a Statement to that Effect
51-100% equity interest; value cannot be readily determined through reference to public prices or other reasonable measures of fair market value.